Zacks Research Issues Positive Outlook for Amarin Earnings
Amarin Co. plc (NASDAQ:AMRN – Free Report) – Investment analysts at Zacks Research boosted their Q2 2025 earnings estimates for Amarin in a research note issued on Wednesday, May 28th. Zacks Research analyst R. Department now anticipates that the biopharmaceutical company will post earnings per share of ($0.87) for the quarter, up from their prior […]
Amarin Co. plc (NASDAQ:AMRN – Free Report) – Investment analysts at Zacks Research boosted their Q2 2025 earnings estimates for Amarin in a research note issued on Wednesday, May 28th. Zacks Research analyst R. Department now anticipates that the biopharmaceutical company will post earnings per share of ($0.87) for the quarter, up from their prior […]
